Grigor Abelian

Safety and efficacy of factor XIa inhibition with milvexian for secondary stroke prevention (AXIOMATIC-SSP): a phase 2, international, randomised, double-blind, placebo-controlled, dose-finding trial

Mukul Sharma, Carlos A. Molina, Ḱazunori Toyoda et al. · The Lancet Neurology · 2023 · 90 citations · Full text

Pharmacy, Neurology, Pharmacotherapy +8

Single-Dose Pharmacokinetics of Milvexian in Participants with Mild or Moderate Hepatic Impairment Compared with Healthy Participants

Vidya Perera, Grigor Abelian, Danshi Li et al. · Clinical Pharmacokinetics · 2022 · 32 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +14

Single-Dose Pharmacokinetics of Milvexian in Participants with Normal Renal Function and Participants with Moderate or Severe Renal Impairment

Vidya Perera, Grigor Abelian, Danshi Li et al. · Clinical Pharmacokinetics · 2022 · 22 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +16

Whose Benchmark Is Right? Validating Venous Thromboembolism Events Between Trauma Registries and Hospital Administrative Databases

Todd A. Miano, Grigor Abelian, Mark J. Seamon et al. · Journal of the American College of Surgeons · 2019 · 12 citations · Full text

Medicine, Biomedical Informatics, Clinical Epidemiology +13

Inhibitors of the Neutral Amino Acid Transporters ASCT1 and ASCT2 Are Effective in In Vivo Models of Schizophrenia and Visual Dysfunction

Yong‐Xin Li, Jiaying Yang, Miguel Alcantara et al. · Journal of Pharmacology and Experimental Therapeutics · 2018 · 10 citations · Full text

Medicine, Neuroscience, Pharmacology +17